Oncology & Hematology Coding Alert

Reader Questions:

Differentiate Between These Codes to Report NETs

Question: One of our oncologists documented “left kidney, NET [neuroendocrine tumor], well differentiated.” When I go to the ICD-10-CM Alphabetic Index, I cannot find an entry for a well-differentiated NET. As the entry for “malignant poorly differentiated” takes me to C7A.1, it would make sense that D3A.8 would be the code for well-differentiated. However, my pathologist says all NETs are malignant and should automat­ically be coded as such. If that is so, then why would the index list both a C and D code for NET?

AAPC Forum Participant

Answer: You are correct in saying that there is a code for a poorly differentiated NET: C7A.1 (Malignant poorly differentiated neuroendocrine tumors). Well-differentiated tumors, as you also point out, do not have their own codes.

From a clinical perspective, your pathologist has a point: All NETs can become malignant over time. But well-differentiated NET cells grow and spread more slowly than poorly differentiated NETs. This is why ICD-10 includes codes for benign neuroendocrine tumors in the D3A.- (Benign neuroendocrine tumors) code group, and a well-differentiated left kidney NET can be coded to D3A.8 (Other benign neuroendocrine tumors).

However, before assigning this code, it would be a good idea for you to work with your provider and your pathologist to make sure their clinical understanding aligns with your coding. This will ensure this encounter has been properly documented.